3 April 2024
DLA Piper advises Symphar on sale to pharmaceutical manufacturer Farmak
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Marta Frąckowiak | DLA Piper | Partner | Corporate | Warsaw |
| Piero Carbone | DLA Piper | Partner | Corporate | London |
| Agnieszka Lechman-Filipiak | DLA Piper | Partner | Employment | Not stated |
| Michał Bałdowski | DLA Piper | Senior associate | Not stated | Not stated |
| Izabela Gębal | DLA Piper | Counsel | Not stated | Not stated |
| Natalia Cichocka | DLA Piper | Associate | Not stated | Not stated |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Symphar sp. z o.o.Sell-side
- Counterparties
- Farmak (Buy-side)